Key result
Abrupt verapamil withdrawal increases angina recurrence ~67% compared to placebo withdrawal.
Why the study?
The potential hazards of abrupt withdrawal of verapamil after six months of treatment in patients with prior myocardial infarction were unclear.
Does abrupt withdrawal of verapamil increase the risk of worsening or reappearance of angina pectoris in patients six months post-myocardial infarction?
RCT (n=472)
Double-blind
Yes
Does abrupt withdrawal of verapamil increase the risk of worsening or reappearance of angina pectoris in patients six months post-myocardial infarction?
Abrupt withdrawal of verapamil six months post-myocardial infarction leads to a mild but statistically significant increase in worsening or reappearance of angina pectoris, though no severe withdrawal syndrome was observed.
Answers are grounded in this paper and cite their sources.
No withdrawal syndrome after abrupt verapamil cessation post-MI; leaves open whether tapering reduces angina recurrence in symptomatic patients.
In order to examine the potential hazards of abrupt withdrawal of verapamil 120 mg t.i.d. after six months treatment, a double blind placebo controlled study was designed as part of the Danish multicenter trial of verapamil in acute myocardial infarction. All patients had had a myocardial infarction six months before withdrawal. At the time of withdrawal 30% of the verapamil and 28% of the placebo treated patients were experiencing angina pectoris. At follow-up after two to three weeks 15% of 212 patients in the verapamil treated group and 9% of 260 patients in the placebo treated group reported worsening or reappearance of angina pectoris (P<0.05). One patient in the placebo group developed a myocardial infarction, and one patient in the verapamil group had episodes of supraventricular tachycardia after withdrawal. A ‘withdrawal syndrome’ was not found.
No takes yet. Share an insight, caveat, or question.
THE DANISH STUDY GROUP ON VERAPAMIL IN MYOCARDIAL INFARCTION (1984) conducted an RCT in Ischaemic heart disease (n=472). Verapamil vs. Placebo was evaluated on Worsening or reappearance of angina pectoris (p=<0.05). Abrupt withdrawal of verapamil after 6 months of treatment led to worsening or reappearance of angina pectoris in 15% of patients versus 9% in the placebo group.
Synapse has enriched 10 related papers. Consider them for comparative context: